Massy Holdings Ltd. (JMSE:MASSY)

Market Cap	180.77B
Revenue (ttm)	372.33B
Net Income (ttm)	16.91B
Shares Out	n/a
EPS (ttm)	8.54
PE Ratio	10.69
Forward PE	n/a
Dividend	4.83 (6.28%)
Ex-Dividend Date	May 29, 2025

Volume	145
Average Volume	34,051
Open	n/a
Previous Close	77.49
Day's Range	77.00 - 77.48
52-Week Range	65.00 - 95.01
Beta	n/a
RSI	48.87
Earnings Date	Aug 8, 2025

About Blueprint Medicines

Massy Holdings Ltd., together with its subsidiaries, engages in trading, service industries, and finance business in Trinidad and Tobago, the Barbados and Eastern Caribbean region, Guyana, Jamaica, Colombia, and the United States. The company operates through four segments: Integrated Retail, Gas Products, Motors and Machines, and Financial Services. It is involved in the retail and wholesale distribution of pharmaceuticals, foods, and general merchandise; sale of liquified petroleum gases and industrial gases, including nitrogen, oxygen, and c...

• Industry: Conglomerates
• Founded: 1923
• Employees: 13,828
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: MASSY

Financial Performance

In 2024, Massy Holdings's revenue was 15.72 billion, an increase of 10.76% compared to the previous year's 14.20 billion. Earnings were 660.60 million, a decrease of -13.56%.